Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-14

Clinical Trial Update: The Cognitive Resilience Study [NA]

View source ↗

Summary

Duke University's Cognitive Resilience Study for Alzheimer disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Alzheimer Disease | NA | Status: COMPLETED